Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An mTORC1-GRASP55 signaling axis controls unconventional secretion to reshape the extracellular proteome upon stress. | Mol Cell | 2021 | 34245671 | PubTator, text mining | PubMed |
| Molecular mechanism of microRNA-26a regulation of phosphatase and tensin homolog gene in condyloma acuminatum and penile squamous cell carcinoma. | J Int Med Res | 2021 | 34232796 | PubTator, text mining | PubMed |
| Engineering large-scale chromosomal deletions by CRISPR-Cas9. | Nucleic Acids Res | 2021 | 34230973 | PubTator, text mining | PubMed |
| Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer. | J Pers Med | 2021 | 34204015 | PubTator, text mining | PubMed |
| PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening. | Biomedicines | 2021 | 34203351 | PubTator, text mining | PubMed |
| Proteogenomics Reveals Orthologous Alternatively Spliced Proteoforms in the Same Human and Mouse Brain Regions with Differential Abundance in an Alzheimer's Disease Mouse Model. | Cells | 2021 | 34201730 | PubTator, text mining | PubMed |
| Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential. | Cancers (Basel) | 2021 | 34200174 | PubTator, text mining | PubMed |
| Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors. | Curr Issues Mol Biol | 2021 | 34199766 | PubTator, text mining | PubMed |
| MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis. | Int J Mol Sci | 2021 | 34199293 | PubTator, text mining | PubMed |
| Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer. | Cancers (Basel) | 2021 | 34198652 | PubTator, text mining | PubMed |
| Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth. | Cell Rep Med | 2021 | 34195686 | PubTator, text mining | PubMed |
| LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636/GLCE axis. | Cancer Cell Int | 2021 | 34193130 | PubTator, text mining | PubMed |
| Deletion of a pseudogene within a fragile site triggers the oncogenic expression of the mitotic CCSER1 gene. | Life Sci Alliance | 2021 | 34187875 | PubTator, text mining | PubMed |
| Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing. | Clin Transl Med | 2021 | 34185421 | PubTator, text mining | PubMed |
| Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17. | Aging (Albany NY) | 2021 | 34182543 | PubTator, text mining | PubMed |
| Evaluation of MLPA as a comprehensive molecular cytogenetic tool to detect cytogenetic markers of chronic lymphocytic leukemia in Egyptian patients. | J Genet Eng Biotechnol | 2021 | 34181122 | PubTator, text mining | PubMed |
| Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential. | Front Cell Dev Biol | 2021 | 34179009 | PubTator, text mining | PubMed |
| Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With In Vitro Derived Conventional Dendritic Cells. | Front Immunol | 2021 | 34177915 | PubTator, text mining | PubMed |
| Evidence of Common Isolates of Streptococcus agalactiae in Bovines and Humans in Emilia Romagna Region (Northern Italy). | Front Microbiol | 2021 | 34177854 | PubTator, text mining | PubMed |
| Nickel-catalyzed asymmetric reductive cross-coupling of α-chloroesters with (hetero)aryl iodides. | Chem Sci | 2021 | 34168828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=55